Discover 419 paid clinical trials in Lexington, Kentucky. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 419
Clinical Trial Evaluating the Safety and Efficacy of Nucleus Pulposus Allograft in Participants With Degenerative Disc Disease
for
Degenerative Disc Disease, Disc Degeneration,
Location: Lexington KY, New Castle IN, Charleston WV,
Sponsor: VIVEX Biologics, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06778447
Recruiting
A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)
for
Non-small Cell Lung Cancer
Location: Lexington KY, Baltimore MD, Philadelphia PA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06731907
Phase2, Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Get alerts for new trials in your area by subscribing now
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Lexington KY, Columbus OH, Richmond VA, Springdale AR,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase2, Phase3, Recruiting
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
for
Lung Neoplasm
Location: Lexington KY, Baltimore MD, Dallas TX
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06780098
Phase2, Recruiting
Spinal Decompression Plus Nerve Graft Implantation Following TSCI
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer